Home

Astrazeneca Pharma India Ltd 52 Week Low

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

YEARLOW

₹ 4050.15

Last updated on: Feb 21, 2025

Key Highlights

  • The 52 Week Low of Astrazeneca Pharma India Ltd is ₹ 4050 as of 21 Feb 25 .

Company Fundamentals for Astrazeneca Pharma India Ltd

Market Price of Astrazeneca Pharma India Ltd

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20256868.75
20 Feb 20256976.5
19 Feb 20256942.7
18 Feb 20256958
17 Feb 20257030.05
14 Feb 20257096.35
13 Feb 20257410.6
12 Feb 20257494.65
11 Feb 20257466.85
10 Feb 20257535.1

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Net Profit of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Astrazeneca Pharma India Ltd News Hub

AstraZeneca slumps on recording dismal Q1 performance

Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter ended 30

Read more

08 Aug 24

Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter

Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as ag

Read more

08 Aug 24

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI

Read more

24 Sept 24

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and National Alumini

Read more

24 Sept 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Astrazeneca Pharma India Ltd

Why is it important to track the 52-week low of Astrazeneca Pharma India Ltd stocks?

Investors should monitor the 52-week low of Astrazeneca Pharma India Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Astrazeneca Pharma India Ltd stocks hitting a 52-week low?

Factors leading to Astrazeneca Pharma India Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Astrazeneca Pharma India Ltd stocks when they hit a 52-week low?

Buying Astrazeneca Pharma India Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Astrazeneca Pharma India Ltd stocks?

Investors should monitor the 52-week low of Astrazeneca Pharma India Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Astrazeneca Pharma India Ltd stock at their 52-week low?

An investor can analyze the reasons for the Astrazeneca Pharma India Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Astrazeneca Pharma India Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Astrazeneca Pharma India Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Astrazeneca Pharma India Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions